Your browser is no longer supported. Please, upgrade your browser.
Settings
APOP [NASD]
Cellect Biotechnology Ltd.
Index- P/E- EPS (ttm)-12.08 Insider Own3.65% Shs Outstand129.43M Perf Week-13.61%
Market Cap47.46M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.57M Perf Month-39.71%
Income-5.60M PEG- EPS next Q- Inst Own12.20% Short Float2.20% Perf Quarter-19.07%
Sales- P/S- EPS this Y37.90% Inst Trans- Short Ratio0.13 Perf Half Y53.94%
Book/sh0.04 P/B361.75 EPS next Y- ROA-72.60% Target Price- Perf Year68.26%
Cash/sh1.62 P/C8.96 EPS next 5Y- ROE-92.20% 52W Range6.60 - 35.52 Perf YTD67.48%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-59.26% Beta1.85
Dividend %- Quick Ratio5.80 Sales past 5Y- Gross Margin- 52W Low119.31% ATR1.66
Employees12 Current Ratio5.80 Sales Q/Q- Oper. Margin- RSI (14)33.92 Volatility5.02% 9.02%
OptionableNo Debt/Eq0.04 EPS Q/Q50.30% Profit Margin- Rel Volume0.10 Prev Close14.95
ShortableYes LT Debt/Eq0.02 Earnings- Payout- Avg Volume598.85K Price14.47
Recom- SMA20-20.20% SMA50-25.84% SMA200-2.01% Volume61,880 Change-3.21%
Sep-25-17Reiterated H.C. Wainwright Buy $12 → $14
Oct-15-21 04:01PM  
Sep-28-21 12:38PM  
Sep-27-21 02:30PM  
12:11PM  
12:00PM  
10:15AM  
09:10AM  
Sep-07-21 04:58AM  
Sep-03-21 03:26PM  
12:03PM  
12:01PM  
10:10AM  
07:01AM  
Sep-02-21 04:20PM  
Aug-24-21 04:16PM  
Aug-13-21 04:20PM  
Jun-16-21 06:58PM  
May-17-21 08:50AM  
04:50AM  
Apr-19-21 12:10PM  
08:00AM  
Mar-29-21 09:29AM  
Mar-25-21 07:58AM  
07:12AM  
Mar-24-21 05:26PM  
Mar-09-21 11:56AM  
Nov-20-20 08:00AM  
Oct-29-20 11:55AM  
Oct-22-20 08:00AM  
Sep-21-20 08:30AM  
Aug-12-20 08:00AM  
Aug-06-20 08:30AM  
May-21-20 04:15PM  
04:00PM  
May-18-20 08:00AM  
May-12-20 10:09AM  
08:48AM  
May-11-20 02:13AM  
Apr-27-20 10:19AM  
Apr-03-20 08:00AM  
Apr-02-20 08:00AM  
Mar-05-20 10:05AM  
Mar-04-20 11:20AM  
08:00AM  
Feb-09-20 09:38AM  
Jan-08-20 10:05AM  
09:08AM  
Jan-07-20 08:57AM  
07:00AM  
Dec-23-19 07:00AM  
Nov-19-19 07:00AM  
Nov-11-19 06:29AM  
Nov-07-19 08:00AM  
Aug-13-19 12:28PM  
08:00AM  
Aug-12-19 11:35AM  
07:00AM  
Jul-08-19 07:00AM  
May-21-19 07:00AM  
May-16-19 07:00AM  
07:00AM  
Mar-27-19 08:00AM  
Mar-18-19 04:15PM  
Mar-12-19 08:15AM  
Mar-11-19 09:35AM  
07:00AM  
Feb-13-19 05:00PM  
Feb-08-19 12:55AM  
Feb-05-19 07:30AM  
Jan-28-19 07:00AM  
Jan-23-19 07:20AM  
Dec-17-18 07:00AM  
Nov-21-18 08:45AM  
Nov-13-18 07:00AM  
Nov-05-18 07:00AM  
Nov-01-18 07:00AM  
Oct-22-18 08:00AM  
Oct-18-18 07:00AM  
Oct-15-18 07:16AM  
Aug-20-18 07:00AM  
Aug-13-18 07:00AM  
Aug-09-18 04:15PM  
Aug-07-18 07:00AM  
Jul-09-18 07:00AM  
Jul-05-18 07:00AM  
May-17-18 04:59PM  
May-10-18 07:00AM  
Apr-09-18 07:00AM  
Mar-19-18 04:15PM  
Feb-01-18 12:00PM  
11:43AM  
Jan-29-18 08:00AM  
Jan-16-18 07:00AM  
Jan-05-18 01:11PM  
Jan-04-18 08:52AM  
07:45AM  
Nov-22-17 07:00AM  
Nov-10-17 07:00AM  
Oct-31-17 08:58AM  
Oct-25-17 10:51AM  
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische UniversitAt Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was incorporated in 1986 and is headquartered in Kfar Saba, Israel.